MODENDO INC.

Medtech · Private

Multi-probe ultrathin endomicroscope with real-time imaging and photo-stimulation for deep brain access

Grants
$3.3M
5 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Multi-probe minimally invasive endomicroscope$450,000
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Multi-probe minimally invasive endomicroscope$121,255
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Multi-probe minimally invasive endomicroscope$238,840
Federal grantNational Science Foundation · Phase II · SBIR Phase II: Ultrathin endomicroscope$994,138
Federal grantDepartment of Health and Human Services · Phase II · SBIR Phase II: Multi-probe minimally invasive endomicroscope$1,499,367
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2060NEUROLIGHT, INC.——
2061ACCELERATED MUSCLE BIOTECHNOLOGIES CONSULTANTS, L.L.C.——
2062BIODEVEK INC——
2063MODENDO INC.——
2064HEXAKIT INC——
2065Bionic Eye Technologies, Inc.——
2066OPTOSURGICAL LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.